Implementing Ultra-high-pressure LC (UHPLC) in Pharmaceutical Analysis: Best Practices and Potential Issues
This Wednesday morning symposium was arranged by Michael Dong of Genentech (San Francisco, California), who also participated in LCGC?s Pittcon Theater on Monday.
Session 1320
Room 316, 8:00 a.m.
This Wednesday morning symposium was arranged by Michael Dong of Genentech (San Francisco, California), who also participated in LCGC’s Pittcon Theater on Monday.
Dong will kick off this symposium with his opening remarks followed by a presentation entitled, "UHPLC in Pharmaceutical Analysis: Perspectives, Performance and Issues." This will be a great session to attend for anyone who came to Monday's Pittcon Theater presentation by Dong- and for those who didn't as well!
After this presentation, Naijun Wu from Merck and Co. will take the stage with a discussion on UHPLC in pharmaceutical process development. Next up will be Klaus Witt from Agilent Technologies who will be discussing issues and solutions with method transfer between HPLC and UHPLC.
Qinglin Tang from Merck and Co. will present, "Implementation of UHPLC in Pharmaceutical QC Laboratories," next. The final presentation in this group will come from Taylor Zhang of Genentech and will discuss UHPLC for therapeutic protein characterization.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
